Published in Br J Haematol on February 01, 1968
Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A. J Clin Invest (1973) 1.76
Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet (1967) 5.38
The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest (1968) 3.66
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest (1973) 2.94
Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases. Blood (1968) 2.73
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest (1973) 2.71
Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med (1974) 2.44
Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med (1975) 2.31
Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res (1978) 2.14
Mechanochemical properties of brain clathrin: interactions with actin and alpha-actinin and polymerization into basketlike structures or filaments. Proc Natl Acad Sci U S A (1979) 2.04
Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med (1974) 1.86
Transient arthritis after rubella vaccination. Am J Dis Child (1969) 1.86
Clinical aspects of IgE myeloma. N Engl J Med (1969) 1.85
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest (1977) 1.85
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med (1975) 1.69
Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem (1989) 1.63
Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography. Thromb Diath Haemorrh (1972) 1.61
Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol (1970) 1.57
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Secretable storage pools in platelets. Annu Rev Med (1979) 1.49
Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science (1973) 1.49
Aspirin--a dangerous drug? JAMA (1974) 1.47
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med (1978) 1.46
Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med (1971) 1.46
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J Clin Invest (1976) 1.43
Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood (1978) 1.39
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood (1979) 1.33
Structure of the carbohydrate units of IgE immunoglobulin. II. Sequence of the sialic acid-containing glycopeptides. J Biol Chem (1974) 1.27
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26
Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Am J Med (1972) 1.25
Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med (1968) 1.24
Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol (1970) 1.23
Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia--"storage pool disease". Blood (1972) 1.23
Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood (1986) 1.21
Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest (1984) 1.20
A familialdefect in platelet function associated with imapired release of adenosine diphosphate. N Engl J Med (1969) 1.18
Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med (1979) 1.17
A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins (1973) 1.17
Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med (1967) 1.16
Isolated deficiency of platelet procoagulant activity. Am J Med (1979) 1.15
Red blood cells: their dual role in thrombus formation. Science (1980) 1.13
Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest (1986) 1.13
Adsorption of proteins by polystyrene particles. I. Molecular unfolding and acquired immunogenicity of IgG. J Immunol (1967) 1.13
Thrombocytopathia due to abnormalities in platelet release reaction--studies on six unrelated patients. Blood (1972) 1.12
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost (1981) 1.07
Editorial: Platelet function tests and their interpretation. J Lab Clin Med (1976) 1.06
Regulation of neurotransmitter release by a complex of actin with relaxing protein isolated from rat brain synaptosomes. J Biol Chem (1974) 1.06
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med (1983) 1.06
Von Willebrand's disease--diagnostic criteria. Blood (1968) 1.06
Bilirubin-protein ratio in amniotic fluid as an index of the severity of erythroblastosis fetalis. Obstet Gynecol (1965) 1.05
Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood (1985) 1.05
Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism. J Clin Invest (1974) 1.03
alpha-Actinin and tropomyosin interactions with a hybrid complex of erythrocyte-actin and muscle-myosin. J Biol Chem (1977) 1.02
Antiplatelet therapy (first of two parts). N Engl J Med (1978) 1.02
Content and thrombin-induced release of acid hydrolases in gel-filtered platelets from patients with storage pool disease. Blood (1975) 1.02
Properties of the platelet retention (von Willebrand) factor and its similarity to the antihemophilic factor (AHF). Blood (1973) 1.01
Studies of oleate binding to rat liver plasma membranes. Biochem Biophys Res Commun (1983) 0.98
Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood (1985) 0.97
Thromboembolism--a continuing challenge. N Engl J Med (1970) 0.97
Coexistence of polycythemia vera and biclonal gammopathy (gamma-GK and gamma-AL) with two Bence Jones proteins (BJK and BJL). Blood (1968) 0.97
Heavy chain disease of the gamma (gamma M) type: report of the first case. Blood (1970) 0.97
The effect of shear rate on platelet interaction with subendothelium exposed to citrated human blood. Microvasc Res (1980) 0.96
A solid-liquid biphasic model for characterization of properties of muscle and platelet contractile proteins. J Biol Chem (1975) 0.95
Release of human platelet factor V activity is induced by both collagen and ADP and is inhibited by aspirin. Blood (1980) 0.95
Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment. J Lab Clin Med (1983) 0.95
Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med (1975) 0.94
Ultrastructural findings in storage pool disease and aspirin-like defects of platelets. Am J Pathol (1973) 0.94
Immunohistochemical localization of IgE in asthmatic lungs. Am J Pathol (1971) 0.94
The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: in vivo and in vitro studies. J Lab Clin Med (1967) 0.94
Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thromb Haemost (1977) 0.93
Structure of the carbohydrate units of IgE immunoglobulin. I. Over-all composition, glycopeptide isolation, and structure of the high mannose oligosaccharide unit. J Biol Chem (1974) 0.93
Idiotypic specificities of anti-Rh antibodies. J Immunol (1976) 0.93
Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest (1994) 0.92
Influence of renal failure on myelosuppressive effects of melphalan: Cancer and Leukemia Group B experience. Cancer Treat Rep (1982) 0.91
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis. Am Heart J (1976) 0.90
Instrumented PVP-augmented antiglobulin tests. II. Evaluation of acquired hemolytic anemia. Vox Sang (1974) 0.90
Phylogenetic studies with pemphigus and pemphigoid antibodies. Acta Derm Venereol (1978) 0.90
Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor. Thromb Haemost (1997) 0.89
Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood (1998) 0.89
Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fibrin formation. J Lab Clin Med (1980) 0.89
Metal ion contents of gel-filtered platelets from patients with storage pool disease. Blood (1975) 0.88
Effects of puff adder venom on the coagulation mechanism. I. In vivo. Toxicon (1973) 0.88
Automated methods for the detection and measurement of hemagglutination. Bibl Haematol (1965) 0.88
Afibrinogenemia in man following the bite of a rattlesnake (Crotalus adamanteus). Am J Med (1969) 0.88
Structural studies of immunoglobulin E. I. Physicochemical studies of the IgE molecule. Ann N Y Acad Sci (1971) 0.87
Deficiency of glutathione peroxidase associated with high levels of reduced glutathione in glanzmann's thrombasthenia. N Engl J Med (1972) 0.86
Incidence of severe von Willebrand's disease. N Engl J Med (1982) 0.86
Family studies in Scott syndrome. Blood (1997) 0.85